DHVI Mission: The Duke Human Vaccine Institute will develop innovative diagnostics, vaccines and therapeutics to prevent and treat diseases of global importance, work to implement them to eliminate health disparities, and train the next generation of scientists.
The Duke Human Vaccine Institute (DHVI) has established a place of national and international leadership in the fight against major infectious diseases. DHVI plays an integral leadership role in the Global HIV/AIDS Vaccine Enterprise and is a pioneer in emerging infections and biodefense research. By focusing on the scientific “bottlenecks” for the development of HIV, TB, and other vaccines, DHVI investigators continue to make significant contributions to overcome global health challenges on behalf of society. More
Scanning electron micrograph of HIV particles infecting a human H9 T cell, colorized in blue, turqoise, and yellow. Credit: NIAID
Dr. Sallie Permar Says Zika is Unusual for Mother-to-Child Transmission January 28, 2016 Sallie Permar, MD, PhD, directs the Laboratory of Neonatal Viral Pathogen Immunity at the DHVI. A pediatrician, Permar is also associate professor of immunology and of molecular genetics and microbiology at Duke.